Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study.Marina Elena Cazzaniga, Maria Concetta Cursano, Enrico Maria Romano De Conciliis et al.|Journal of Clinical Oncology|2017Cited by 2
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 StudyMarina Elena Cazzaniga, Valter Torri, Maria Rosaria Valerio et al.|The Breast|2017Cited by 0